Sleep disorder treatment and prevention
AssigneePurdue Pharma L.P.
InventorsStephen C. HARRIS, Ram P. KAPIL, Donald J. KYLE, Garth WHITESIDE
Life of this patent
Estimating the term…
Abstract
The disclosure relates to methods for treating or preventing an Insomnia Disorder by administering to a human in need thereof a compound of formula (I), or a compound of formula (IA), (IB), or (IC), or a solvate thereof, in a daily dose of from about 0.5 mg to about 6.0 mg. In certain embodiments, such compounds effectively treat or prevent an Insomnia Disorder in the animal, while producing reduced side effects compared to previously available compounds.
Claims131
A method for treating or preventing an Insomnia Disorder, comprising administering to a human in need thereof a therapeutically effective amount of a compound of Formula (I)
- in a daily dose of from about 0.5 mg to about 6.0 mg.
A method for treating or preventing Insomnia Associated with Alcohol Cessation, comprising administering to a human in need thereof a therapeutically effective amount of a compound of Formula (I)
A compound of Formula (I)
- for use in a method of treating or preventing an Insomnia Disorder, wherein the daily dose is from about 0.5 mg to about 6.0 mg.
A compound of Formula (I)
- for use in a method for treating or preventing Insomnia Associated with Alcohol Cessation.
Dependencies are inferred from the claim text.